Répertoire des subventions financées

Filtrer par

683 ésultat(s) trouvé(s)

Understanding brain development and maintenance via spatial transcriptomics

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodevelopment

  • Disease Area

    Other

  • Compétition

    Future Leaders in Canadian Brain Research

  • Province

    Manitoba

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

We identified changes in the gene called IRF2BPL (Interferon Regulatory Factor 2 Binding Protein Like) as the cause of a severe brain disorder in children called NEDAMSS (Neurodevelopmental disorder with abnormal movements, loss of speech and seizures). Children with NEDAMSS show typical early development followed by severe symptoms (movement problems,…

Projet en cours

Voir le projet et les chercheurs

A unifying approach to treat multisystem proteinopathy and ALS using noninvasive novel ASO delivery

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Other

  • Compétition

    Future Leaders in Canadian Brain Research

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Multisystem proteinopathy (MSP) is a devastating rare disease described by a cluster of diseases that affect the brain, bone, and muscle. Greater than 50 pathogenic genetic mutations of Valosin-containing protein (VCP) cause MSP. Unfortunately, patients with the mutation, even within the same family, can display any combination of the cluster…

Projet en cours

Voir le projet et les chercheurs

Molecular regulators of extracellular matrix remodeling during Amyotrophic Lateral Sclerosis

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS

  • Compétition

    Future Leaders in Canadian Brain Research

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by the loss of motor neurons and the atrophy of muscles. Approximately 4,000 Canadians are currently living with ALS, a disease diagnosed in ~1,000 citizens every year and eighty percent of people with ALS die within two to five years…

Projet en cours

Voir le projet et les chercheurs

Imaging Endocannabinoid Signalling in Individuals with Cocaine Addiction

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Mental Health

  • Disease Area

    Mental illness

  • Compétition

    Future Leaders in Canadian Brain Research

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Cocaine is a highly addictive stimulant drug. Approximately 10% of Canadians aged 20-24 report current cocaine use. Demand for the drug is growing and rates of cocaine use, across age groups, are rising nationwide. Cocaine addiction is a significant public health concern. It is associated with elevated rates of morbidity…

Projet en cours

Voir le projet et les chercheurs

Does the Epstein-Barr virus activate immune cells before multiple sclerosis becomes symptomatic?

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Multiple Sclerosis

  • Compétition

    Future Leaders in Canadian Brain Research

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Multiple Sclerosis (MS) is a serious chronic neurological condition, particularly common among young adults in Canada. The exact cause of MS is unknown, but it involves immune cells mistakenly attacking the brain and spinal cord. Symptoms often worsen over time and become chronic, leading to eyesight, movement, mood, and/or memory…

Projet en cours

Voir le projet et les chercheurs